Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Evaluation of Sustained Disease Control With Nipocalimab Versus Placebo in the Phase 3 Vivacity-MG3 Study.
Journal: European journal of neurology
Published: October 15, 2025
A novel case of compound heterozygous GFPT1 congenital myasthenic syndrome with a coexisting heterozygous DYSF mutation: clinical and pathological insights.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: September 09, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Journal: JAMA
Published: March 11, 2025
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Journal: JAMA network open
Published: February 17, 2025
Impact of the updated chronic inflammatory demyelinating polyneuropathy guideline on everyday clinical practice.
Journal: Therapeutic advances in neurological disorders
Published: September 01, 2023
Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis.
Journal: Frontiers in neurology
Published: August 28, 2023
Clinical Meaningfulness of Response to Tanezumab in Patients with Chronic Low Back Pain: Analysis From a 56-Week, Randomized, Placebo- and Tramadol-Controlled, Phase 3 Trial.
Journal: Pain and therapy
Published: May 05, 2022
Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant.
Journal: Clinical neurology and neurosurgery
Published: February 03, 2021
Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg.
Journal: Frontiers in neurology
Published: December 07, 2020
Last Updated: 09/26/2026